Bionomics Limited (ASX: BNO, OTCQX: BNOEF) today announced that it will present a poster with new data on the DisrupTOR-1 trial of BNC105 in patients with metastatic renal cancer at the 7th Asian Oncology Summit being held from April 10-12, 2015 in Shanghai, China.
from The Medical News http://ift.tt/1Egg3Ps
from The Medical News http://ift.tt/1Egg3Ps
No comments:
Post a Comment